102 related articles for article (PubMed ID: 20851116)
1. Statins inhibited erythropoietin-induced proliferation of rat vascular smooth muscle cells.
Kaneda T; Tsuruoka S; Fujimura A
Eur J Pharmacol; 2010 Dec; 649(1-3):38-43. PubMed ID: 20851116
[TBL] [Abstract][Full Text] [Related]
2. Effect of statins on the proteasomal activity in mammalian endothelial and vascular smooth muscle cells.
Ludwig A; Friedel B; Metzkow S; Meiners S; Stangl V; Baumann G; Stangl K
Biochem Pharmacol; 2005 Aug; 70(4):520-6. PubMed ID: 15996638
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the efficacies of five different statins on inhibition of human saphenous vein smooth muscle cell proliferation and invasion.
Turner NA; Midgley L; O'Regan DJ; Porter KE
J Cardiovasc Pharmacol; 2007 Oct; 50(4):458-61. PubMed ID: 18049315
[TBL] [Abstract][Full Text] [Related]
4. The role of Rho-associated kinase in differential regulation by statins of interleukin-1beta- and lipopolysaccharide-mediated nuclear factor kappaB activation and inducible nitric-oxide synthase gene expression in vascular smooth muscle cells.
Wei CY; Huang KC; Chou YH; Hsieh PF; Lin KH; Lin WW
Mol Pharmacol; 2006 Mar; 69(3):960-7. PubMed ID: 16317111
[TBL] [Abstract][Full Text] [Related]
5. Statins activate GATA-6 and induce differentiated vascular smooth muscle cells.
Wada H; Abe M; Ono K; Morimoto T; Kawamura T; Takaya T; Satoh N; Fujita M; Kita T; Shimatsu A; Hasegawa K
Biochem Biophys Res Commun; 2008 Oct; 374(4):731-6. PubMed ID: 18671946
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of smooth muscle cell calcium mobilization and aortic ring contraction by lactone vastatins.
Escobales N; Crespo MJ; Altieri PI; Furilla RA
J Hypertens; 1996 Jan; 14(1):115-21. PubMed ID: 12013483
[TBL] [Abstract][Full Text] [Related]
7. Statins prevent pulsatile stretch-induced proliferation of human saphenous vein smooth muscle cells via inhibition of Rho/Rho-kinase pathway.
Kozai T; Eto M; Yang Z; Shimokawa H; Lüscher TF
Cardiovasc Res; 2005 Dec; 68(3):475-82. PubMed ID: 16098957
[TBL] [Abstract][Full Text] [Related]
8. HMG-CoA reductase inhibition reduces the proinflammatory activation of human vascular smooth muscle cells by the terminal complement factor C5b-9.
Viedt C; Shen W; Fei J; Kamimura M; Hänsch GM; Katus HA; Kreuzer J
Basic Res Cardiol; 2003 Nov; 98(6):353-61. PubMed ID: 14556080
[TBL] [Abstract][Full Text] [Related]
9. HMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statins.
Wiesbauer F; Kaun C; Zorn G; Maurer G; Huber K; Wojta J
Br J Pharmacol; 2002 Jan; 135(1):284-92. PubMed ID: 11786505
[TBL] [Abstract][Full Text] [Related]
10. Effects of statin treatment and withdrawal on angiotensin II-induced phosphorylation of p38 MAPK and ERK1/2 in cultured vascular smooth muscle cells.
Tristano AG; Castejon AM; Castro A; Cubeddu LX
Biochem Biophys Res Commun; 2007 Feb; 353(1):11-7. PubMed ID: 17161379
[TBL] [Abstract][Full Text] [Related]
11. Fluvastatin prevents vascular hyperplasia by inhibiting phenotype modulation and proliferation through extracellular signal-regulated kinase 1 and 2 and p38 mitogen-activated protein kinase inactivation in organ-cultured artery.
Sakamoto K; Murata T; Chuma H; Hori M; Ozaki H
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):327-33. PubMed ID: 15591221
[TBL] [Abstract][Full Text] [Related]
12. Lovastatin increases nitric oxide synthesis in IL-1 beta-stimulated smooth muscle cells.
Chen H; Xing Y; Liu R
Chin Med J (Engl); 2001 Nov; 114(11):1123-7. PubMed ID: 11729502
[TBL] [Abstract][Full Text] [Related]
13. Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages.
Luan Z; Chase AJ; Newby AC
Arterioscler Thromb Vasc Biol; 2003 May; 23(5):769-75. PubMed ID: 12663370
[TBL] [Abstract][Full Text] [Related]
14. Statins effect on smooth muscle cell proliferation.
Bellosta S; Arnaboldi L; Gerosa L; Canavesi M; Parente R; Baetta R; Paoletti R; Corsini A
Semin Vasc Med; 2004 Nov; 4(4):347-56. PubMed ID: 15861311
[TBL] [Abstract][Full Text] [Related]
15. Pleiotropic effects of statins in atherosclerosis and diabetes.
Bellosta S; Ferri N; Arnaboldi L; Bernini F; Paoletti R; Corsini A
Diabetes Care; 2000 Apr; 23 Suppl 2():B72-8. PubMed ID: 10860194
[TBL] [Abstract][Full Text] [Related]
16. Lovastatin inhibits gap junctional communication in cultured aortic smooth muscle cells.
Shen J; Wang LH; Zheng LR; Zhu JH; Hu SJ
J Cardiovasc Pharmacol Ther; 2010 Sep; 15(3):296-302. PubMed ID: 20601591
[TBL] [Abstract][Full Text] [Related]
17. Statins suppress MMP2 secretion via inactivation of RhoA/ROCK pathway in pulmonary vascular smooth muscles cells.
Li M; Li Z; Sun X
Eur J Pharmacol; 2008 Sep; 591(1-3):219-23. PubMed ID: 18619957
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol inhibits the mevalonate pathway and potentiates the antiproliferative effects of simvastatin in rat theca-interstitial cells.
Wong DH; Villanueva JA; Cress AB; Sokalska A; Ortega I; Duleba AJ
Fertil Steril; 2011 Nov; 96(5):1252-8. PubMed ID: 21907337
[TBL] [Abstract][Full Text] [Related]
19. Statins inhibit proliferation and induce apoptosis in Barrett's esophageal adenocarcinoma cells.
Ogunwobi OO; Beales IL
Am J Gastroenterol; 2008 Apr; 103(4):825-37. PubMed ID: 18371146
[TBL] [Abstract][Full Text] [Related]
20. Statins inhibit in vitro calcification of human vascular smooth muscle cells induced by inflammatory mediators.
Kizu A; Shioi A; Jono S; Koyama H; Okuno Y; Nishizawa Y
J Cell Biochem; 2004 Nov; 93(5):1011-9. PubMed ID: 15389884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]